A monoclonal antibody (mAb) against a glycoprotein called repulsive guidance molecule-a (RGMa) may provide an efficient therapeutic strategy for treating neuromyelitis optica (NMO), scientists at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results